Piramal Pharma to Invest USD 90 Million in Expanding US FacilitiesMumbai-based Piramal Pharma Limited has made a USD 90 million investment to build out two of its facilities in the US. The announcement comes on the backdrop of the 2025 Select USA...
Emcutix Biopharmaceuticals Ltd., in collaboration with Canada-based Mantra Pharma Inc. – both subsidiaries of Emcure Pharmaceuticals Ltd. – has announced the pan-India launch of Ureaderm 10 percent & 20 percent, a urea-based moisturizer in cream
India Eyes Kuwait Pharma Market Amid Growing Import DemandIn a bid to tap into increasing pharmaceutical demand in Kuwait, the Indian Pharmaceuticals Export Promotion Council of India (Pharmexcil) is seeking comments from Indian pharma...
Solara Active Pharma Sciences reported that its Ambernath facility in Maharashtra, having multiple products manufacturing, passed inspection by the United States Food and Drug Administration (USFDA)...
The Centre's latest move to impose a ban on the export of pharmaceuticals to Pakistan, after the April 22 terror attack in Pahalgam, which killed 26 people, will have negligible or no effect on Himachal Pradesh's pharmaceutical industry...
Senores Pharmaceuticals Limited, a world class research based pharmaceutical firm has made a disclosure that its 100% owned subsidiary...
FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...
According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.
Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...
Indian pharmaceutical companies may encounter significant hurdles in the US following President Donald Trump’s new executive orders aimed at promoting domestic drug production...